People on the Move Archives - Page 33 of 152

eClinical Solutions Appoints Lauren Whitsell as Chief Operating Officer and Venu Mallarapu as Chief Transformation and AI Officer

March 13, 2026

Casma Therapeutics Secures $7.6 Million in MJFF Funding to Advance Parkinson’s Disease Program

March 10, 2026

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

March 5, 2026

THIS WEEK'S STORIES

Qlaris Bio Appoints Fred Guerard, Pharm.D., as President and Chief Executive Officer

March 10, 2026

GelMEDIX, Catalent Partner to Develop Stem Cell-Based Therapies for Ocular and Retinal Diseases

March 11, 2026

Vicarious Surgical Unveils Strategy to Seek Nasdaq Listing While Cutting Cash Burn

March 16, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

People on the Move

Korsana Biosciences Names Mark Vignola, Ph.D., as Chief Financial Officer

eClinical Solutions Appoints Lauren Whitsell as Chief Operating Officer and Venu Mallarapu as Chief Transformation and AI Officer

Aurion Biotech Names Marjan Farid, M.D., Chair of Medical Advisory Board

Cognito Therapeutics Names Thomas Fagan Executive Vice President of Alzheimer’s Portfolio

Qlaris Bio Appoints Fred Guerard, Pharm.D., as President and Chief Executive Officer

Most Read

Boston Maintains Global Life Sciences Leadership Despite Rising Lab Vacancies

Eccogene Enrolls First Patient in Phase 2a Trial Testing ECC4703 With Semaglutide for Obesity

The Hartford Expands Support for Active Minds’ Send Silence Packing Tour to Promote Student Mental Health

Form Health Launches Diabetes Program, Expanding Integrated Cardiometabolic Care for Employers

EDITOR PICKS

eClinical Solutions Appoints Lauren Whitsell as Chief Operating Officer and Venu Mallarapu as Chief Transformation and AI Officer

Casma Therapeutics Secures $7.6 Million in MJFF Funding to Advance Parkinson’s Disease Program

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

THIS WEEK'S STORIES

Qlaris Bio Appoints Fred Guerard, Pharm.D., as President and Chief Executive Officer

GelMEDIX, Catalent Partner to Develop Stem Cell-Based Therapies for Ocular and Retinal Diseases

Vicarious Surgical Unveils Strategy to Seek Nasdaq Listing While Cutting Cash Burn

POPULAR CATEGORY

ABOUT US

FOLLOW US